Literature DB >> 24039351

Epidemiology of esophageal cancer.

Yuwei Zhang1.   

Abstract

Esophageal cancer (EsC) is one of the least studied and deadliest cancers worldwide because of its extremely aggressive nature and poor survival rate. It ranks sixth among all cancers in mortality. In retrospective studies of EsC, smoking, hot tea drinking, red meat consumption, poor oral health, low intake of fresh fruit and vegetables, and low socioeconomic status have been associated with a higher risk of esophageal squamous cell carcinoma. Barrett's esophagus is clearly recognized as a risk factor for EsC, and dysplasia remains the only factor useful for identifying patients at increased risk, for the development of esophageal adenocarcinoma in clinical practice. Here, we investigated the epidemiologic patterns and causes of EsC. Using population based cancer data from the Surveillance, Epidemiology and End Results Program of the United States; we generated the most up-to-date stage distribution and 5-year relative survival by stage at diagnosis for 1998-2009. Special note should be given to the fact that esophageal cancer, mainly adenocarcinoma, is one of the very few cancers that is contributing to increasing death rates (20%) among males in the United States. To further explore the mechanism of development of EsC will hopefully decrease the incidence of EsC and improve outcomes.

Entities:  

Keywords:  Barrett’s esophagus; Cyclin D1 G870A; Esophageal neoplasm; Polymorphism; Risk factor; Susceptibility

Mesh:

Year:  2013        PMID: 24039351      PMCID: PMC3769895          DOI: 10.3748/wjg.v19.i34.5598

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  87 in total

1.  Invited commentary: more evidence of increased risks of cancer among alcohol drinkers.

Authors:  W J Blot
Journal:  Am J Epidemiol       Date:  1999-12-01       Impact factor: 4.897

2.  Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.

Authors:  Chunyuan Yu; Wenfu Lu; Wen Tan; Deyin Xing; Gang Liang; Xiaoping Miao; Dongxin Lin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

3.  [Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].

Authors:  I Szántó; A Vörös; G Gonda; P Nagy; A Altorjay; J Banai; E M Gamal; E Cserepes
Journal:  Magy Seb       Date:  2001-06

Review 4.  Barrett's esophagus-related diseases remain uncommon in China.

Authors:  Qin Huang; Dian Chun Fang; Cheng Gong Yu; Jun Zhang; Min Hu Chen
Journal:  J Dig Dis       Date:  2011-12       Impact factor: 2.325

5.  Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.

Authors:  E P Xing; G Y Yang; L D Wang; S T Shi; C S Yang
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

6.  Continuing climb in rates of esophageal adenocarcinoma: an update.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

7.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

Review 8.  Epidemiology and risk factors for oesophageal adenocarcinoma.

Authors:  Côme Lepage; Antoine Drouillard; Jean-Louis Jouve; Jean Faivre
Journal:  Dig Liver Dis       Date:  2013-02-28       Impact factor: 4.088

Review 9.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

10.  Endoscopic surveys in high-risk and low-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer.

Authors:  Y Guanrei; Q Songliang
Journal:  Endoscopy       Date:  1987-05       Impact factor: 10.093

View more
  370 in total

1.  Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy.

Authors:  Pragatheeshwar Thirunavukarasu; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven N Hochwald; Steven J Nurkin
Journal:  Int J Surg       Date:  2015-11-18       Impact factor: 6.071

2.  Cold atmospheric plasma induced genotoxicity and cytotoxicity in esophageal cancer cells.

Authors:  Hanieh Estarabadi; Seyed Alireza Atyabi; Sajjad Tavakkoli; Zahra Noormohammadi; Mohamad Reza Gholami; Ali Ghiaseddin; Shiva Irani
Journal:  Mol Biol Rep       Date:  2021-02-06       Impact factor: 2.316

3.  Tissue classification of oncologic esophageal resectates based on hyperspectral data.

Authors:  Marianne Maktabi; Hannes Köhler; Margarita Ivanova; Boris Jansen-Winkeln; Jonathan Takoh; Stefan Niebisch; Sebastian M Rabe; Thomas Neumuth; Ines Gockel; Claire Chalopin
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-06-20       Impact factor: 2.924

4.  A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Authors:  John M Poneros; Adam S Faye; Emily G Barr Fritcher; Ananda Sen; Sharmila Anandasabapathy; Robert S Bresalier; Norman Marcon; D Kim Turgeon; Henry Appelman; Daniel Normolle; Larry E Morrison; Dean E Brenner; Kevin C Halling
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

5.  Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Wenyu Wang; Xiaoyan Li; Tianhui Gao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?

Authors:  R N Sharan; S Thangminlal Vaiphei; Saibadaiahun Nongrum; Joshua Keppen; Mandahakani Ksoo
Journal:  Cell Oncol (Dordr)       Date:  2015-09-18       Impact factor: 6.730

7.  Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.

Authors:  Kotaro Yamashita; Masayuki Watanabe; Shinji Mine; Takanori Kurogochi; Akihiko Okamura; Masaru Hayami; Yu Imamura
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

8.  Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.

Authors:  Ren Zhang; Xiaonan Chen; Shengjie Zhang; Xueyan Zhang; Tong Li; Zhicai Liu; Jinwu Wang; Wenqiao Zang; Yuanyuan Wang; Yuwen Du; Guoqiang Zhao
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

9.  SCREENING FOR BARRETT'S ESOPHAGUS WITH PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY VIDEOS.

Authors:  J Vince Pulido; Shan Guleria; Lubaina Ehsan; Tilak Shah; Sana Syed; Don E Brown
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2020-05-22

Review 10.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.